Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
BlueVoyant Unveils New Outcomes-Based Cyber Defense Platform: BlueVoyant Elements™ 2022-06-07 21:00
Telix to Present at Jefferies Healthcare Conference 2022-06-07 19:00
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT 2022-06-07 19:00
China Matters Explores the birthplace of Cantonese Culture 2022-06-07 17:30
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand 2022-06-07 16:00
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand 2022-06-07 16:00
CapitaLand Investment acquires 22-storey office tower in Melbourne's CBD 2022-06-07 11:29
P.I. Works and VMware To Bolster O-RAN Adoption and Innovation 2022-06-07 09:00
Werkflo Releases the new FlowBiz™ suite 2022-06-07 06:00
Telix Showcasing Innovation in Theranostics at SNMMI 2022-06-07 05:00
500 Financial Institutions now Live on the Taskize Network 2022-06-06 21:44
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer 2022-06-06 21:08
Locus Unveils Order-to-Delivery Dispatch Management Platform to Transform Complex Last-Mile Logistics Operations 2022-06-06 21:00
Medison Pharma Announces Multi-Regional Partnership Agreement with argenx to Commercialize Efgartigimod Across Europe and Israel 2022-06-06 19:00
SocietyOne launches transaction & savings accounts powered by Westpac 2022-06-06 09:25
Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform 2022-06-06 07:00
Gold Globee® Recognition Annature and founder CEO Amreeta Abbott at the Golden Bridge Awards 2022-06-06 07:00
KAZIA PRESENTS POSITIVE FINAL DATA FROM PHASE II STUDY OF PAXALISIB IN NEWLY DIAGNOSED GLIOBLASTOMA AT ASCO CONFERENCE 2022-06-03 19:00
China Matters Featured the Impact of a 1,000-Year-Old Legacy in Today's China 2022-06-02 21:15
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy 2022-06-02 20:00
1 164 165 166 167 168 460